Vertex Pharmaceuticals Inc
Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –
Accumulated other comprehensive income (loss) của Vertex Pharmaceuticals theo quý
Accumulated other comprehensive income (loss) ($M) ($M)
Accumulated other comprehensive income (loss) của Vertex Pharmaceuticals: $48.5M trong Q2 2026, giảm 148.0% so với cùng kỳ năm trước.
Số của Q2 2026 lấy từ đâu
Nguồn: Form 10-Q (filed 2026-08-04) ↗
Được báo cáo trong Form 10-Q / 10-K (DB).
Lịch sử theo quý
Rê chuột vào một số để xem câu chữ đã đọc ra số đó; số tự tính sẽ hiện công thức
| Kỳ | Kết thúc | Accumulated other comprehensive income (loss) ($M) ($M) | So với cùng kỳ | Nguồn |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 48.5 | -148.0% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 24.8 | -63.6% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | -15.9 | -112.4% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | -64.5 | -324.0% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | -101 | -549.3% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 68.1 | +293.6% | Form 10-Q (filed 2025-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 128 | -993.7% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 28.8 | -1,060.0% | Form 10-Q (filed 2024-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 22.5 | -156.5% | Form 10-Q (filed 2024-08-02) ↗ |
| Q1 2024 | Mar 31, 2024 | 17.3 | -232.1% | Form 10-Q (filed 2024-05-07) ↗ |
| Q4 2023 | Dec 31, 2023 | -14.3 | -1,887.5% | Form 10-K (filed 2024-02-15) ↗ |
| Q3 2023 | Sep 30, 2023 | -3 | -103.1% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | -39.8 | -169.2% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | -13.1 | -215.9% | Form 10-Q (filed 2023-05-02) ↗ |
| Q4 2022 | Dec 31, 2022 | 0.80 | -95.0% | Form 10-K (filed 2023-02-10) ↗ |
| Q3 2022 | Sep 30, 2022 | 97.6 | +748.7% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2022 | Jun 30, 2022 | 57.5 | -328.2% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 11.3 | -133.9% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 15.9 | -123.2% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2021 | Sep 30, 2021 | 11.5 | -128.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | -25.2 | +78.7% | Form 10-Q (filed 2021-07-30) ↗ |
| Q1 2021 | Mar 31, 2021 | -33.3 | -348.5% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | -68.5 | +3,325.0% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | -41 | -318.1% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2020 | Jun 30, 2020 | -14.1 | +340.6% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 13.4 | +123.3% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | -2 | -385.7% | Form 10-K (filed 2020-02-13) ↗ |
| Q3 2019 | Sep 30, 2019 | 18.8 | +6,166.7% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | -3.20 | -30.4% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2019 | Mar 31, 2019 | 6 | -115.1% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 0.70 | -106.0% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 0.30 | -101.2% | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | -4.60 | -78.9% | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | -39.7 | -348.1% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | -11.6 | -154.7% | Form 10-K (filed 2018-02-15) ↗ |
| Q3 2017 | Sep 30, 2017 | -25.1 | +560.5% | Form 10-Q (filed 2017-10-30) ↗ |
| Q2 2017 | Jun 30, 2017 | -21.8 | +541.2% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 16 | -426.5% | Form 10-Q (filed 2017-04-28) ↗ |
| Q4 2016 | Dec 31, 2016 | 21.2 | +1,077.8% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Sep 30, 2016 | -3.80 | -353.3% | Form 10-Q (filed 2016-10-31) ↗ |
| Q2 2016 | Jun 30, 2016 | -3.40 | +100.0% | Form 10-Q (filed 2016-08-01) ↗ |
| Q1 2016 | Mar 31, 2016 | -4.90 | -712.5% | Form 10-Q (filed 2016-05-03) ↗ |
| Q4 2015 | Dec 31, 2015 | 1.80 | +100.0% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | 1.50 | +25.0% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | -1.70 | – | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 0.80 | -366.7% | Form 10-Q (filed 2015-05-04) ↗ |
| Q4 2014 | Dec 31, 2014 | 0.90 | -400.0% | Form 10-K (filed 2015-02-13) ↗ |
| Q3 2014 | Sep 30, 2014 | 1.20 | -340.0% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | -0 | -100.0% | Form 10-Q (filed 2014-07-31) ↗ |
| Q1 2014 | Mar 31, 2014 | -0.30 | -72.7% | Form 10-Q (filed 2014-05-05) ↗ |
| Q4 2013 | Dec 31, 2013 | -0.30 | -40.0% | Form 10-K (filed 2014-02-11) ↗ |
| Q3 2013 | Sep 30, 2013 | -0.50 | +25.0% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | -1.20 | +71.4% | Form 10-Q (filed 2013-08-02) ↗ |
| Q1 2013 | Mar 31, 2013 | -1.10 | +83.3% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | -0.50 | -54.5% | Form 10-K (filed 2013-03-01) ↗ |
| Q3 2012 | Sep 30, 2012 | -0.40 | -55.6% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | -0.70 | 0.0% | Form 10-Q (filed 2012-08-08) ↗ |
| Q1 2012 | Mar 31, 2012 | -0.60 | 0.0% | Form 10-Q (filed 2012-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | -1.10 | 0.0% | Form 10-K (filed 2012-02-22) ↗ |
| Q3 2011 | Sep 30, 2011 | -0.90 | +28.6% | Form 10-Q (filed 2011-11-03) ↗ |
| Q2 2011 | Jun 30, 2011 | -0.70 | +16.7% | Form 10-Q (filed 2011-08-09) ↗ |
| Q1 2011 | Mar 31, 2011 | -0.60 | -45.5% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | -1.10 | +83.3% | Form 10-K (filed 2011-02-17) ↗ |
| Q3 2010 | Sep 30, 2010 | -0.70 | – | Form 10-Q (filed 2010-10-28) ↗ |
| Q2 2010 | Jun 30, 2010 | -0.60 | – | Form 10-Q (filed 2010-08-03) ↗ |
| Q1 2010 | Mar 31, 2010 | -1.10 | – | Form 10-Q (filed 2010-05-03) ↗ |
| Q4 2009 | Dec 31, 2009 | -0.60 | – | Form 10-Q (filed 2010-05-03) ↗ |
Trích dẫn dữ liệu này
StockData. (2026). Accumulated other comprehensive income (loss) ($M) của Vertex Pharmaceuticals, theo quý Q4 2009–Q2 2026 [Bộ dữ liệu]. Tổng hợp từ Hồ sơ SEC và tài liệu dành cho nhà đầu tư của Vertex Pharmaceuticals. https://stockdatahq.com/stocks/vrtx/kpis/fs-aoci
Xem mọi chỉ số ở bảng KPI của Vertex Pharmaceuticals. Dữ liệu cập nhật Nov 2, 2026.
See a number that looks wrong?